[go: up one dir, main page]

GB9519029D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9519029D0
GB9519029D0 GBGB9519029.4A GB9519029A GB9519029D0 GB 9519029 D0 GB9519029 D0 GB 9519029D0 GB 9519029 A GB9519029 A GB 9519029A GB 9519029 D0 GB9519029 D0 GB 9519029D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9519029.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Priority to GBGB9519029.4A priority Critical patent/GB9519029D0/en
Publication of GB9519029D0 publication Critical patent/GB9519029D0/en
Priority to PCT/CA1996/000616 priority patent/WO1997010823A1/en
Priority to AU69211/96A priority patent/AU6921196A/en
Priority to EA199800204A priority patent/EA199800204A1/en
Priority to IL12353696A priority patent/IL123536A0/en
Priority to PL96325560A priority patent/PL325560A1/en
Priority to ES96929991T priority patent/ES2191106T3/en
Priority to TR1998/00488T priority patent/TR199800488T1/en
Priority to JP51226097A priority patent/JP3411292B2/en
Priority to AT96929991T priority patent/ATE230988T1/en
Priority to CZ98826A priority patent/CZ82698A3/en
Priority to DE69625819T priority patent/DE69625819T2/en
Priority to EP96929991A priority patent/EP0851756B1/en
Priority to CN96198141A priority patent/CN1201390A/en
Priority to HU9900606A priority patent/HUP9900606A2/en
Priority to CA002231887A priority patent/CA2231887A1/en
Priority to BR9610526A priority patent/BR9610526A/en
Priority to KR1019980701969A priority patent/KR19990045728A/en
Priority to IS4686A priority patent/IS4686A/en
Priority to MXPA/A/1998/002001A priority patent/MXPA98002001A/en
Priority to NO981188A priority patent/NO981188L/en
Pending legal-status Critical Current

Links

GBGB9519029.4A 1995-09-18 1995-09-18 Medicaments Pending GB9519029D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB9519029.4A GB9519029D0 (en) 1995-09-18 1995-09-18 Medicaments
KR1019980701969A KR19990045728A (en) 1995-09-18 1996-09-16 5-HT3 receptor antagonist for dyskinesia
CZ98826A CZ82698A3 (en) 1995-09-18 1996-09-16 Use of 5-ht3 receptor antagonists for preparing a pharmaceutical preparation for treating dikinesis
EP96929991A EP0851756B1 (en) 1995-09-18 1996-09-16 Use of ondansetron in the manufacture of a medicament for the treatment of tremor
EA199800204A EA199800204A1 (en) 1995-09-18 1996-09-16 5-Ht 3? receptor antagonists for dyskinesia
IL12353696A IL123536A0 (en) 1995-09-18 1996-09-16 5-HT3 Receptor antagonists for dyskinesia
PL96325560A PL325560A1 (en) 1995-09-18 1996-09-16 Inhibitors of 5-ht 3 receptors in treating diskinesis
ES96929991T ES2191106T3 (en) 1995-09-18 1996-09-16 USE OF ONDANSETRON IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF THE TEMBLOR.
TR1998/00488T TR199800488T1 (en) 1995-09-18 1996-09-16 5-HT3 receptor antagonists for dyskinesia.
JP51226097A JP3411292B2 (en) 1995-09-18 1996-09-16 5-HT3 receptor antagonist for dyskinesia
AT96929991T ATE230988T1 (en) 1995-09-18 1996-09-16 THE USE OF ONDANSETRON IN THE PRODUCTION OF A MEDICATION FOR THE TREATMENT OF TREMOR
PCT/CA1996/000616 WO1997010823A1 (en) 1995-09-18 1996-09-16 5-ht3 receptor antagonists for dyskinesia
DE69625819T DE69625819T2 (en) 1995-09-18 1996-09-16 THE USE OF ONDANSETRON FOR PRODUCING A MEDICINE FOR TREATING TREMOR
AU69211/96A AU6921196A (en) 1995-09-18 1996-09-16 5-ht3 receptor antagonists for dyskinesia
CN96198141A CN1201390A (en) 1995-09-18 1996-09-16 5-HT3 receptor antagonists for treating dyskinesia
HU9900606A HUP9900606A2 (en) 1995-09-18 1996-09-16 5-HT3 receptor antagonists for the treatment of movement disorders
CA002231887A CA2231887A1 (en) 1995-09-18 1996-09-16 5-ht3 receptor antagonists for dyskinesia
BR9610526A BR9610526A (en) 1995-09-18 1996-09-16 Use of a 5-HT3 receptor antagonist or a pharmaceutically acceptable derivative thereof for the treatment of a mammal including man suffering from dyskinesia and said antagonist
IS4686A IS4686A (en) 1995-09-18 1998-03-09 5-HT3 receptor antagonists for motor failure
MXPA/A/1998/002001A MXPA98002001A (en) 1995-09-18 1998-03-13 Antagonists of receiver 5-th3 for discine
NO981188A NO981188L (en) 1995-09-18 1998-03-17 5-HT3 receptor antagonists for dyskinesia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9519029.4A GB9519029D0 (en) 1995-09-18 1995-09-18 Medicaments

Publications (1)

Publication Number Publication Date
GB9519029D0 true GB9519029D0 (en) 1995-11-15

Family

ID=10780871

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9519029.4A Pending GB9519029D0 (en) 1995-09-18 1995-09-18 Medicaments

Country Status (1)

Country Link
GB (1) GB9519029D0 (en)

Similar Documents

Publication Publication Date Title
HUP9801151A3 (en) Long-shelf-life medicaments
ZA966969B (en) Medicaments
AP9700951A0 (en) Medicaments
GB9406573D0 (en) Medicaments
GB9420784D0 (en) Medicaments
GB9526392D0 (en) Medicaments
GB9503850D0 (en) Medicaments
GB9418530D0 (en) Medicaments
GB9411052D0 (en) Medicaments
GB9421133D0 (en) Medicaments
GB9416365D0 (en) Medicaments
EP0790829A4 (en) Medicaments
GB9506122D0 (en) Medicaments
GB9524173D0 (en) Medicaments
GB9523453D0 (en) Medicaments
GB9521208D0 (en) Medicaments
GB9519585D0 (en) Medicaments
GB9519021D0 (en) Medicaments
GB9515628D0 (en) Medicaments
GB9519029D0 (en) Medicaments
GB9514723D0 (en) Medicaments
GB9504153D0 (en) Medicaments
IL127776A0 (en) Medicaments
GB9517021D0 (en) Medicaments
GB9424013D0 (en) Medicaments